Skip to main content

Table 3 Post-intervention changes in Vancomycin therapy and trough levels

From: Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible

Variables

3 to 6 months

 > 6 month–2 years

 > 2 to 6 years

 > 6 to 12 years

N = 31

N = 39

N = 45

N = 24

dose (mg/kg/day)

Median (range)

70 (70–80)

78 (65–85)

75 (70–85)

69 (70–80)

Mean

(± SD)

71 ± 18

75 ± 9.9

73 ± 15

65 ± 18

interval/frequency (hourly)

Median (range)

6

6

6

6

Achieved target vancomycin trough levels within 10-20 mg/L

  Yes- with changed dose

31 (100.0%)

39 (100.0%)

44 (97.8%)

22 (91.7%)

  Mean (± SD)

11.1 ± 0.9

12.3 ± 2.1

10.4 ± 0.2

12.8 ± 1.3

  No- with changed dose

0.00 (0.0%)

0.00 (0.0%)

1 (2.2%)

02 (8.3%) a

  Mean (± SD)

-

-

4.2 ± 2.0

25.6 ± 3.3

  1. aSupratherapeutic levels